Pyxis Oncology annual gross margin
2024
2025
Pyxis Oncology Gross Margin Growth & History (PYXS)
Pyxis Oncology's gross margin was 82.77% for fiscal 2025.
View full Pyxis Oncology company overviewPyxis Oncology annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 82.77% | −14.29 pp |
| 2024 | 2024-12-31 | 97.06% | — |
Pyxis Oncology quarterly gross margin
Q1.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | 78.37% | — |
| Q2 2025 | 2025-06-30 | 100.00% | — |
| Q1 2024 | 2024-03-31 | 97.06% | — |
Pyxis Oncology gross margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Pyxis Oncology's gross margin decreased from 97.06% to 82.77%, a change of −14.29 percentage points. The latest reported quarter, Q4 2025, shows 78.37%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pyxis Oncology source filings ↗